Pathogenic and Protective Autoantibodies in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED)

Area of Science:

• Immunology
• Genetics
• Endocrinology

Background:

• Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a rare autoimmune disorder.
• It results from mutations in the autoimmune regulator (AIRE) gene, impacting T cell selection.
• APECED patients exhibit autoimmune tissue destruction and immunodeficiency, notably chronic mucocutaneous candidiasis.

Purpose of the Study:

• To review the antigenic targets of antibodies in APECED patients.
• To elucidate the function of disease-causing and disease-ameliorating antibodies in APECED.
• To provide a comprehensive understanding of antibody-mediated pathology in this rare condition.

Main Methods:

• Literature review of studies on APECED and associated antibodies.
• Analysis of reported antigenic targets and antibody specificities.
• Evaluation of functional data regarding antibody roles in disease pathogenesis and modulation.

Main Results:

• APECED is characterized by a diverse range of high-affinity antibodies targeting specific tissues and cytokines.
• These antibodies play dual roles, contributing to autoimmune destruction while potentially ameliorating disease severity in some contexts.
• The AIRE gene's role in central tolerance is crucial for preventing such autoantibody production.

Conclusions:

• Antibodies are central players in the complex pathology of APECED.
• Understanding antibody targets and functions is key to developing targeted therapies.
• Further research into AIRE's function and autoantibody mechanisms is warranted.